182 related articles for article (PubMed ID: 36549665)
1. What the Hel: recent advances in understanding rifampicin resistance in bacteria.
Sudzinová P; Šanderová H; Koval' T; Skálová T; Borah N; Hnilicová J; Kouba T; Dohnálek J; Krásný L
FEMS Microbiol Rev; 2023 Nov; 47(6):. PubMed ID: 36549665
[TBL] [Abstract][Full Text] [Related]
2. Mycobacterium abscessus HelR interacts with RNA polymerase to confer intrinsic rifamycin resistance.
Hurst-Hess KR; Saxena A; Rudra P; Yang Y; Ghosh P
Mol Cell; 2022 Sep; 82(17):3166-3177.e5. PubMed ID: 35905736
[TBL] [Abstract][Full Text] [Related]
3. HelR is a helicase-like protein that protects RNA polymerase from rifamycin antibiotics.
Surette MD; Waglechner N; Koteva K; Wright GD
Mol Cell; 2022 Sep; 82(17):3151-3165.e9. PubMed ID: 35907401
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RNA Polymerase by Rifampicin and Rifamycin-Like Molecules.
Mosaei H; Zenkin N
EcoSal Plus; 2020 Apr; 9(1):. PubMed ID: 32342856
[TBL] [Abstract][Full Text] [Related]
5.
Cutugno L; Mc Cafferty J; Pané-Farré J; O'Byrne C; Boyd A
Microbiology (Reading); 2020 Dec; 166(12):1160-1170. PubMed ID: 33186092
[TBL] [Abstract][Full Text] [Related]
6. Rifampicin-resistance, rpoB polymorphism and RNA polymerase genetic engineering.
Alifano P; Palumbo C; Pasanisi D; Talà A
J Biotechnol; 2015 May; 202():60-77. PubMed ID: 25481100
[TBL] [Abstract][Full Text] [Related]
7. Cross-resistance of Escherichia coli RNA polymerases conferring rifampin resistance to different antibiotics.
Xu M; Zhou YN; Goldstein BP; Jin DJ
J Bacteriol; 2005 Apr; 187(8):2783-92. PubMed ID: 15805525
[TBL] [Abstract][Full Text] [Related]
8. Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungi.
Kirsch SH; Haeckl FPJ; Müller R
Nat Prod Rep; 2022 Jun; 39(6):1226-1263. PubMed ID: 35507039
[TBL] [Abstract][Full Text] [Related]
9. Linking system-wide impacts of RNA polymerase mutations to the fitness cost of rifampin resistance in Pseudomonas aeruginosa.
Qi Q; Preston GM; MacLean RC
mBio; 2014 Dec; 5(6):e01562. PubMed ID: 25491352
[TBL] [Abstract][Full Text] [Related]
10. Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.
Peek J; Lilic M; Montiel D; Milshteyn A; Woodworth I; Biggins JB; Ternei MA; Calle PY; Danziger M; Warrier T; Saito K; Braffman N; Fay A; Glickman MS; Darst SA; Campbell EA; Brady SF
Nat Commun; 2018 Oct; 9(1):4147. PubMed ID: 30297823
[TBL] [Abstract][Full Text] [Related]
11. Analysing the fitness cost of antibiotic resistance to identify targets for combination antimicrobials.
Rasouly A; Shamovsky Y; Epshtein V; Tam K; Vasilyev N; Hao Z; Quarta G; Pani B; Li L; Vallin C; Shamovsky I; Krishnamurthy S; Shtilerman A; Vantine S; Torres VJ; Nudler E
Nat Microbiol; 2021 Nov; 6(11):1410-1423. PubMed ID: 34697460
[TBL] [Abstract][Full Text] [Related]
12. Mutations compensating for the fitness cost of rifampicin resistance in Escherichia coli exert pleiotropic effect on RNA polymerase catalysis.
Kurepina N; Chudaev M; Kreiswirth BN; Nikiforov V; Mustaev A
Nucleic Acids Res; 2022 Jun; 50(10):5739-5756. PubMed ID: 35639764
[TBL] [Abstract][Full Text] [Related]
13. Stationary phase induced alterations in mycobacterial RNA polymerase assembly: A cue to its phenotypic resistance towards rifampicin.
Mukherjee R; Chatterji D
Biochem Biophys Res Commun; 2008 May; 369(3):899-904. PubMed ID: 18328810
[TBL] [Abstract][Full Text] [Related]
14. The antibiotic sorangicin A inhibits promoter DNA unwinding in a
Lilic M; Chen J; Boyaci H; Braffman N; Hubin EA; Herrmann J; Müller R; Mooney R; Landick R; Darst SA; Campbell EA
Proc Natl Acad Sci U S A; 2020 Dec; 117(48):30423-30432. PubMed ID: 33199626
[TBL] [Abstract][Full Text] [Related]
15. High-resolution landscape of an antibiotic binding site.
Yang KB; Cameranesi M; Gowder M; Martinez C; Shamovsky Y; Epshtein V; Hao Z; Nguyen T; Nirenstein E; Shamovsky I; Rasouly A; Nudler E
Nature; 2023 Oct; 622(7981):180-187. PubMed ID: 37648864
[TBL] [Abstract][Full Text] [Related]
16. Rifampicin can induce antibiotic tolerance in mycobacteria via paradoxical changes in rpoB transcription.
Zhu JH; Wang BW; Pan M; Zeng YN; Rego H; Javid B
Nat Commun; 2018 Oct; 9(1):4218. PubMed ID: 30310059
[TBL] [Abstract][Full Text] [Related]
17. Rifampicin Resistance Associated with
Schaeffer J; Lippert K; Pleininger S; Stöger A; Hasenberger P; Stadlbauer S; Heger F; Eigentler A; Geusau A; Indra A; Allerberger F; Ruppitsch W
Microbiol Spectr; 2022 Jun; 10(3):e0275721. PubMed ID: 35678576
[TBL] [Abstract][Full Text] [Related]
18. Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase.
Severinov K; Soushko M; Goldfarb A; Nikiforov V
J Biol Chem; 1993 Jul; 268(20):14820-5. PubMed ID: 8325861
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis.
Brandis G; Pietsch F; Alemayehu R; Hughes D
J Antimicrob Chemother; 2015 Mar; 70(3):680-5. PubMed ID: 25362573
[TBL] [Abstract][Full Text] [Related]
20. Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis.
Mosaei H; Molodtsov V; Kepplinger B; Harbottle J; Moon CW; Jeeves RE; Ceccaroni L; Shin Y; Morton-Laing S; Marrs ECL; Wills C; Clegg W; Yuzenkova Y; Perry JD; Bacon J; Errington J; Allenby NEE; Hall MJ; Murakami KS; Zenkin N
Mol Cell; 2018 Oct; 72(2):263-274.e5. PubMed ID: 30244835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
